Home > M&A deals 2020 > Capiton AG acquires CNP Pharma GmbH
Buyout (LBO, MBO, MBI) · Life Science · July 2020

Capiton AG acquires CNP Pharma GmbH

On July 24, 2020, Capiton AG acquired CNP Pharma GmbH, a life science company in Germany.

Deal at a glance

AnnouncedJuly 24, 2020 TypeBuyout (LBO, MBO, MBI) TargetCNP Pharma GmbH Buyer Capiton AG SectorLife Science LocationGermany ValueNot disclosed

Target company

CNP Pharma GmbH
Germany
Life Sciencesector
1890founded
Activestatus
View the company profile →

Buyer

Private equity firm · 47 deals on record
  • 2nd transaction in life science
  • 32nd transaction in Germany
47deals, all time
2in this sector
2021latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Tubulis GmbHSame sector and country · Apr 2026
STADA Arzneimittel AGSame sector and country · Mar 2026
Tubulis GmbHSame sector and country · Mar 2024

Questions about this deal

Who acquired CNP Pharma GmbH?Capiton AG acquired CNP Pharma GmbH on July 24, 2020.

What type of deal was it?It was a buyout (lbo, mbo, mbi) in the life science sector in 2020.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).